Tavexia Lifecare Ltd
Tavexia Lifecare Ltd (TAVEXIA) last reported results for the quarter ended Jun 2026, with sales of ₹0.64 crore and net profit of ₹-0.16 crore. The stock last traded at ₹1.18, a market capitalisation of ₹45.3 crore. Over the past 52 weeks the stock has ranged between ₹0.49 and ₹1.24. Figures are as of 6 Oct 2026 and are not real time.
Tavexia Lifecare Ltd share price and key metrics
- Current price
- ₹1.18
- Market cap
- ₹45.3 cr
- Book value
- ₹1.13
- ROE
- -0.57%
- ROCE
- -0.11%
- Dividend yield
- 0.00%
- 52w high / low
- 1.24/0.49
Metrics as of 6 Oct 2026. Not real time.
Track Tavexia Lifecare Ltd
Cruxal reads every Tavexia Lifecare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Tavexia Lifecare Ltd growth and returns
- 10 Years
- %
- 5 Years
- 90%
- 3 Years
- 144%
- TTM
- 447%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -103%
- 10 Years
- %
- 5 Years
- -16%
- 3 Years
- 5%
- 1 Year
- 39%
- 10 Years
- %
- 5 Years
- 5%
- 3 Years
- 5%
- Last Year
- -1%
Tavexia Lifecare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹0.64 cr, down 47.5% from ₹1.22 cr a year earlier. Net profit swung to a loss of ₹0.16 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1.56 | 1.96 | 1.05 | 1.22 | 16.84 | 5.69 | 8.5 | 0.64 |
| Expenses | 0.64 | 0.9 | 0.27 | 0.44 | 15.68 | 6.23 | 15.03 | 0.88 |
| Operating profit | 0.92 | 1.06 | 0.78 | 0.78 | 1.16 | -0.54 | -6.53 | -0.24 |
| OPM % | 58.97% | 54.08% | 74.29% | 63.93% | 6.89% | -9.49% | -76.82% | -37.50% |
| Other income | 0.04 | 0 | 0.26 | 0 | 0.04 | 0 | 5.85 | 0.12 |
| Interest | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 |
| Depreciation | 0.1 | 0.09 | 0.12 | 0.08 | 0.13 | 0.16 | 0.18 | 0.14 |
| Profit before tax | 0.85 | 0.96 | 0.91 | 0.69 | 1.06 | -0.71 | -0.87 | -0.31 |
| Tax % | 27.06% | 27.08% | 7.69% | 5.80% | 25.47% | -1.41% | -18.39% | -48.39% |
| Net profit | 0.62 | 0.69 | 0.84 | 0.65 | 0.78 | -0.7 | -0.71 | -0.16 |
| EPS (₹) | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | -0.01 | -0.01 | -0.00 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Tavexia Lifecare Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 0.43 | 1.29 | 1.54 | 2.21 | 3.55 | 5.26 | 32.23 | 31.67 |
| Operating profit | 0.07 | 0.66 | 0.1 | 1.07 | 1.97 | 3.29 | -5.07 | -6.15 |
| OPM % | 16.28% | 51.16% | 6.49% | 48.42% | 55.49% | 62.55% | -15.73% | -19.42% |
| Net profit | 0 | 0.44 | 0.02 | 0.55 | 1.19 | 2.49 | 0.21 | -0.79 |
| EPS (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.01 | 0.00 |
TTM is the trailing twelve months to the most recent quarter.
Tavexia Lifecare Ltd balance sheet
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 3.20 | 3.20 | 8.05 | 12.05 | 19.25 | 38.36 |
| Reserves | 0.44 | 0.51 | 7.43 | 10.14 | 4.71 | 4.87 |
| Borrowings | 0.10 | 0.10 | 0.24 | 0.17 | 0.52 | 3.51 |
| Other liabilities | 0.51 | 0.64 | 0.64 | 0.92 | 2.15 | 64.61 |
| Total liabilities | 4.25 | 4.45 | 16.36 | 23.28 | 26.63 | 111.35 |
| Fixed assets | 0.00 | 0.15 | 1.51 | 1.13 | 1.15 | 3.79 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.03 | 8.13 | 10.89 | 10.89 | 12.75 |
| Other assets | 4.25 | 4.27 | 6.72 | 11.26 | 14.59 | 94.81 |
| Total assets | 4.25 | 4.45 | 16.36 | 23.28 | 26.63 | 111.35 |
As reported by the company. Total assets equal total liabilities by construction.
Tavexia Lifecare Ltd cash flow
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | -0.59 | -0.92 | -1.47 | -2.77 | 0.11 | -14.34 |
| Cash from investing | -0.08 | 0.73 | -9.68 | -2.77 | -0.48 | -3.61 |
| Cash from financing | 0.87 | 0.03 | 11.16 | 5.51 | 0.37 | 19.32 |
| Net cash flow | 0.20 | -0.16 | 0.01 | -0.03 | 0.00 | 1.37 |
| Free cash flow | -0.67 | -1.14 | -3.05 | -2.77 | -0.37 | -17.53 |
| CFO / operating profit | -89% | -920% | -118% | -123% | 25% | 282% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Tavexia Lifecare Ltd operating ratios
| Per year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | — | 1.06% | 8.70% | 8.35% | 13.79% | -0.11% |
| Debtor days | 384.81 | 457.44 | 498.78 | 512.03 | 385.12 | 124.69 |
| Inventory days | 1,460.00 | 542.94 | 2,578.55 | 1,034.76 | 2,403.97 | 81.13 |
| Days payable | 538.81 | 173.38 | 412.10 | 180.73 | 528.62 | 581.04 |
| Cash conversion cycle | 1,306.00 | 827.00 | 2,665.23 | 1,366.06 | 2,260.47 | -375.22 |
| Working capital days | 449.88 | 822.44 | 959.57 | 1,039.48 | 843.11 | 284.71 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Tavexia Lifecare Ltd shareholding pattern
Promoters held 6.39% at Jun 2026, up from 3.62% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 3.11% | 3.63% | 3.62% | 3.62% | 6.40% | 6.40% | 6.39% | 6.39% |
| Public | 96.88% | 96.37% | 96.39% | 96.39% | 93.60% | 93.60% | 93.61% | 93.61% |
| No. of shareholders | 8,735 | 17,417 | 29,258 | 33,017 | 35,984 | 37,375 | 36,620 | 35,910 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Tavexia Lifecare Ltd corporate filings
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations,2018Company Updatelow impact
- Tavexia Lifecare Ltd files disclosure under Regulation 30Company Updatelow impact
Cruxal's analysis: The company, with a market cap of approximately 45.65 crore, has made a regulatory…
Read the full analysis - Tavexia Lifecare Limited Approves Acquisition of Up to 60% Stake in Meyonex Pharmaceuticals for ₹67.19 CroreBoard Meetinghigh impact
Cruxal's analysis: Tavexia Lifecare Limited has announced the approval of a strategic acquisition of up to…
Read the full analysis - Company holds AGM with high voting turnout; Resolutions on financials, appointment of auditors, and related party transactions passed with overwhelming supportAGM/EGMhigh impact
Cruxal's analysis: Tavexia Lifecare Limited conducted its 46th AGM on 30th September 2026 via video…
Read the full analysis - Tavexia Lifecare Limited conducts 46th AGM; no new financial disclosures or strategic updates providedAGM/EGMlow impact
Cruxal's analysis: Tavexia Lifecare Limited held its 46th AGM on September 30, 2026, via video conferencing…
Read the full analysis - Board Meeting Scheduled to Discuss Acquisition of Up to 60% Stake in Meyonex Pharmaceuticals; Financial Results PendingBoard Meetingmedium impact
Cruxal's analysis: Tavexia Lifecare Limited has announced a board meeting scheduled for 7th October 2026 to…
Read the full analysis - Promoter Group of Tavexia Lifecare Limited Disposes 2.5 Lakh Equity Shares via On-Market TransactionInsider Trading / SASTlow impact
Cruxal's analysis: Roshan Dealmark Private Limited, part of the promoter group of Tavexia Lifecare Limited…
Read the full analysis - Intimation of Trading Window Closure with effect from Thursday 1st October 2026 for declaration of Un-audited financial results along with limited review report for the Quarter ended September ....Insider Trading / SASTlow impact
- Roshan Dealmark Private Limited Disposes 7 Lakh Equity Shares of Tavexia Lifecare Limited via On-Market TradeInsider Trading / SASTmedium impact
Cruxal's analysis: Roshan Dealmark Private Limited, part of the promoter group of Tavexia Lifecare Limited…
Read the full analysis - Roshan Dealmark Private Limited Disposes 2 Lakh Equity Shares of Tavexia Lifecare LimitedInsider Trading / SASTlow impact
Cruxal's analysis: Roshan Dealmark Private Limited, part of the promoter group, has disposed of 2 lakh…
Read the full analysis - Roshan Dealmark Private Limited Disposes 4 Lakh Equity Shares of Tavexia Lifecare LimitedInsider Trading / SASTlow impact
Cruxal's analysis: Roshan Dealmark Private Limited, part of the promoter group, has executed an on-market…
Read the full analysis - Promoter Entity Roshan Dealmark Private Limited Divests 9.07 Lakh Shares of Tavexia Lifecare LimitedInsider Trading / SASTmedium impact
Cruxal's analysis: Roshan Dealmark Private Limited, part of the promoter group of Tavexia Lifecare Limited…
Read the full analysis - Roshan Dealmark Private Limited Disposes 2.80 Lakh Shares of Tavexia Lifecare Limited via On-Market TransactionInsider Trading / SASTlow impact
Cruxal's analysis: Roshan Dealmark Private Limited, a promoter entity, has offloaded 2.80 lakh equity shares…
Read the full analysis - Promoter Group of Tavexia Lifecare Limited Disposes 10 Lakh Equity Shares via On-Market TradeInsider Trading / SASTmedium impact
Cruxal's analysis: Roshan Dealmark Private Limited, part of the promoter group of Tavexia Lifecare Limited…
Read the full analysis - Promoter Group of Tavexia Lifecare Limited Divests 8.01 Lakh Equity Shares via Open MarketInsider Trading / SASTmedium impact
Cruxal's analysis: Roshan Dealmark Private Limited, part of the promoter group of Tavexia Lifecare Limited…
Read the full analysis - Roshan Dealmark Private Limited Divests 14 Lakh Shares of Tavexia Lifecare Limited via On-Market TransactionInsider Trading / SASTmedium impact
Cruxal's analysis: Roshan Dealmark Private Limited, a member of the promoter group, has disposed of 14 lakh…
Read the full analysis - Tavexia Lifecare Ltd submits newspaper publication regarding 46th Annual Report and remote e-votingCompany Updatelow impact
Cruxal's analysis: Tavexia Lifecare Ltd has filed a copy of its newspaper advertisement confirming the…
Read the full analysis - Roshan Dealmark Private Limited Disposes 18 Lakh Shares of Tavexia Lifecare Limited via On-Market TransactionInsider Trading / SASTmedium impact
Cruxal's analysis: Roshan Dealmark Private Limited, a member of the promoter group, has offloaded 18 lakh…
Read the full analysis - Tavexia Lifecare Ltd schedules 46th Annual General Meeting for September 30, 2026Company Updatelow impact
Cruxal's analysis: Tavexia Lifecare Ltd has submitted a copy of its newspaper publication regarding the 46th…
Read the full analysis - Tavexia Lifecare Limited Announces 46th AGM with Proposals for Related Party Transactions up to INR 100 CroreAGM/EGMmedium impact
Cruxal's analysis: Tavexia Lifecare Limited has issued a notice for its 46th Annual General Meeting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.